Picture of Burning Rock Biotech logo

BNR Burning Rock Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

REG - Stock Exch Notice - Admission to Trading - 01/11/2022

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221101:nRSA7968Ea&default-theme=true

RNS Number : 7968E  London Stock Exchange Notice  01 November 2022

NOTICE OF ADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE

 

01/11/2022 - 08:00

 

The following securities are admitted to trading on the LSE with effect from
the time and date of this notice

 

 BURNING ROCK BIOTECH LIMITED
 106,139,986  American Depositary Shares (Each representing one class A ordinary share of  (BMD5LR9)(US12233L1070)
              USD0.0002 each), fully paid

 

If you have any queries relating to the above, please contact Market
Operations at the LSE on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  SENMBBFTMTAJBBT

Recent news on Burning Rock Biotech

See all news